Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

10515	Companies
221772	Keywords
150978	Articles
117313	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 02/14/2025 at 12:28, 1 year 3 months ago

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q4 revenues of $1.0B with a net loss of $(1.1)B. Forecasts 2025 revenue of $1.5-2.5B. Submitted 3 mRNA products for regulatory approval. Financial details and pipeline updates disclosed

Revenues Net Loss Moderna MRNA Products 2025 Revenue
BRIEF

published on 01/29/2025 at 13:05, 1 year 4 months ago

Moderna to Announce Financial Results for Q4 and 2024

Financial Results Webcast Corporate Update MRNA Technology Moderna
PRESS RELEASE

published on 01/29/2025 at 13:00, 1 year 4 months ago

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
Moderna, Inc. to host conference call on February 14, 2025 to report Q4 and full year 2024 financial results, and provide a corporate update. Details on webcast available on Moderna website

Financial Results Conference Call Webcast Moderna Inc. MRNA Medicine
BRIEF

published on 01/24/2025 at 12:35, 1 year 4 months ago

Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply

COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
PRESS RELEASE

published on 01/24/2025 at 12:30, 1 year 4 months ago

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Moderna awarded tender to supply mRNA COVID-19 vaccine in EU, Norway, and North Macedonia, offering diverse formats like prefilled syringes. Enhancing vaccination campaigns with efficient options

COVID-19 Moderna MRNA Vaccine Vaccination Campaigns Prefilled Syringes
BRIEF

published on 01/17/2025 at 22:33, 1 year 4 months ago

Moderna Advances mRNA-Based Influenza Vaccine Development

Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE

published on 01/17/2025 at 22:28, 1 year 4 months ago

Moderna Announces Updates on Pandemic Influenza Program
Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium

Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF

published on 01/13/2025 at 13:05, 1 year 4 months ago

Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference

Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
PRESS RELEASE

published on 01/13/2025 at 13:00, 1 year 4 months ago

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines

Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF

published on 11/25/2024 at 13:05, 1 year 6 months ago

Moderna to Present at December 2024 Investor Conferences

Investor Conferences Healthcare Webcast MRNA Technology Moderna

Accesswire

Published on 06/04/2026 at 18:25, 47 minutes ago

Touchstone Exploration Inc. Proposed Fundraise of US$10 Million to US$15 Million
Published on 06/04/2026 at 14:45, 4 hours 27 minutes ago

Gedeon Richter Highlights Expanding Biosimilars Portfolio and Scientific Engagement at EULAR 2026
Published on 06/04/2026 at 14:30, 4 hours 42 minutes ago

Predictiv AI's Shift Technologies Secures Multi-Phase Commercial Contract to Digitize and Scale Middle-Mile and Last-Mile Logistics for Prompt Xpress
Published on 06/04/2026 at 14:00, 5 hours 12 minutes ago

Horizon Aircraft Appoints Richard Alexander as Chief Engineer of Certified Programs
Published on 06/04/2026 at 14:00, 5 hours 12 minutes ago

GameSquare Issues Shareholder Letter Highlighting Strong Second Quarter and Year-to-Date Momentum

View all ACCESSWIRE

EQS Group

Published on 06/04/2026 at 18:30, 41 minutes ago

FROM DUPLANTIS TO PALTRINIERI, FAIR PLAY MENARINI KICKS OFF ITS 30TH EDITION
Published on 06/04/2026 at 17:57, 1 hour 14 minutes ago

EQS-Adhoc: Viscom SE raises its forecast for incoming orders in the 2026 financial year following a major contract
Published on 06/04/2026 at 17:50, 1 hour 21 minutes ago

Monport Laser Showcases Engraving Opportunities in Germany Ahead of World Cup 2026
Published on 06/04/2026 at 17:15, 1 hour 56 minutes ago

Tishman Speyer Secures $300 Million First Close for Korea Living Venture with APG and Bouwinvest
Published on 06/04/2026 at 16:05, 3 hours 6 minutes ago

New Brandwatch Research Reveals the 'Question Gap' Between Search Intent and Social Context

Les Echos

Published on 06/04/2026 at 18:23, 48 minutes ago

Shareholders’ Meeting and board of directors’ meeting held on June 4, 2026
Published on 06/04/2026 at 18:00, 1 hour 12 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of May 29, 2026
Published on 06/04/2026 at 17:45, 1 hour 27 minutes ago

Declaration of voting rights at the end of May 2026
Published on 06/04/2026 at 17:45, 1 hour 27 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 06/04/2026 at 17:45, 1 hour 27 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE